Compounds > 4-amino-n-(2,6-dimethylphenyl)phthalimide
Page last updated: 2024-09-03

4-amino-n-(2,6-dimethylphenyl)phthalimide and besipirdine

4-amino-n-(2,6-dimethylphenyl)phthalimide has been researched along with besipirdine in 1 studies

Compound Research Comparison

Studies
(4-amino-n-(2,6-dimethylphenyl)phthalimide)		Trials
(4-amino-n-(2,6-dimethylphenyl)phthalimide)		Recent Studies (post-2010)
(4-amino-n-(2,6-dimethylphenyl)phthalimide)		Studies
(besipirdine)		Trials
(besipirdine)		Recent Studies (post-2010) (besipirdine)
5001531

Protein Interaction Comparison

ProteinTaxonomy4-amino-n-(2,6-dimethylphenyl)phthalimide (IC50)besipirdine (IC50)
Tissue alpha-L-fucosidaseHomo sapiens (human)0.25
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)2.1644
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)2.3133
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)2.3133
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)2.3133
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)2.3133
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)10
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.295
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.295
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.295
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)10
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)10

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anger, T; Madge, DJ; Mulla, M; Riddall, D1

Reviews

1 review(s) available for 4-amino-n-(2,6-dimethylphenyl)phthalimide and besipirdine

ArticleYear
Medicinal chemistry of neuronal voltage-gated sodium channel blockers.
    Journal of medicinal chemistry, 2001, Jan-18, Volume: 44, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Models, Molecular; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Protein Binding; Sodium Channel Blockers; Sodium Channels; Stroke

2001